Katongole owns 2.79 percent of the company, which translates to 101,933,042 ordinary shares.
CiplaQCIL is a pharmaceutical company based in Luzira, a suburb of Kampala, the capital city of Uganda.
The growth in his stake follows a rise in the shares of CiplaQCIL on the Uganda Stock Exchange.
